Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jennifer Kiser

Concepts (362)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antiviral Agents
34
2026
772
6.080
 Why?
Hepatitis C
15
2026
257
4.320
 Why?
Hepatitis C, Chronic
15
2026
153
3.980
 Why?
Anti-HIV Agents
35
2025
908
3.930
 Why?
HIV Infections
56
2025
3189
3.830
 Why?
Adenine
30
2025
338
3.810
 Why?
Sofosbuvir
14
2026
61
3.720
 Why?
Ribavirin
15
2020
81
3.600
 Why?
Drug Interactions
21
2019
404
3.100
 Why?
Tenofovir
31
2025
300
2.990
 Why?
Tandem Mass Spectrometry
17
2025
566
2.140
 Why?
Hepacivirus
13
2026
244
1.960
 Why?
Proline
6
2026
82
1.800
 Why?
Dried Blood Spot Testing
13
2024
126
1.730
 Why?
Oligopeptides
8
2015
266
1.660
 Why?
Organophosphates
16
2025
179
1.650
 Why?
Emtricitabine
19
2025
209
1.600
 Why?
Organophosphonates
12
2014
97
1.470
 Why?
Benzimidazoles
8
2026
187
1.410
 Why?
Ritonavir
8
2021
75
1.360
 Why?
Protease Inhibitors
4
2020
101
1.320
 Why?
Chromatography, Liquid
14
2025
445
1.230
 Why?
Coinfection
5
2024
144
1.200
 Why?
Phosphorous Acids
3
2019
15
1.120
 Why?
Fluorenes
4
2020
46
1.030
 Why?
Pyrophosphatases
3
2016
26
1.010
 Why?
Hepatitis B
4
2024
66
0.990
 Why?
Nucleotides
3
2016
130
0.990
 Why?
Drug Monitoring
8
2024
400
0.920
 Why?
Anti-Retroviral Agents
5
2019
251
0.870
 Why?
Drug Therapy, Combination
12
2018
1046
0.810
 Why?
Sulfonamides
6
2026
581
0.810
 Why?
Pyridines
5
2015
607
0.740
 Why?
Polyphosphates
7
2022
45
0.720
 Why?
Humans
104
2026
145491
0.710
 Why?
Cell Phone
1
2022
82
0.700
 Why?
Reverse Transcriptase Inhibitors
5
2014
87
0.700
 Why?
Erythrocytes
8
2016
751
0.700
 Why?
HIV Protease Inhibitors
5
2011
69
0.700
 Why?
Carbamates
3
2026
51
0.680
 Why?
Membrane Transport Proteins
4
2016
153
0.670
 Why?
Simeprevir
2
2018
5
0.670
 Why?
Viral Load
11
2024
528
0.660
 Why?
Isoniazid
3
2026
71
0.660
 Why?
HIV-1
7
2021
905
0.650
 Why?
Mobile Applications
1
2022
198
0.610
 Why?
Therapies, Investigational
1
2019
18
0.610
 Why?
Antitubercular Agents
3
2026
216
0.590
 Why?
Heterocyclic Compounds, 3-Ring
2
2023
44
0.580
 Why?
Medication Adherence
12
2022
543
0.570
 Why?
Respiratory Syncytial Virus Infections
1
2020
139
0.570
 Why?
Leukocytes, Mononuclear
9
2025
573
0.560
 Why?
Adult
47
2026
40707
0.550
 Why?
Ethanol
1
2023
632
0.550
 Why?
Male
57
2026
72817
0.540
 Why?
Pyridazines
2
2021
57
0.540
 Why?
Antiretroviral Therapy, Highly Active
4
2015
279
0.540
 Why?
Solid Phase Extraction
2
2014
25
0.520
 Why?
Middle Aged
40
2026
36176
0.520
 Why?
Lung Transplantation
1
2020
330
0.500
 Why?
Pyrimidinones
2
2008
125
0.500
 Why?
HIV Integrase Inhibitors
1
2018
79
0.500
 Why?
Inosine
1
2016
14
0.490
 Why?
Liver
2
2016
1895
0.490
 Why?
Tuberculosis
3
2026
292
0.490
 Why?
Guanosine
1
2016
40
0.490
 Why?
Pharmacogenomic Variants
1
2016
33
0.480
 Why?
Heterocyclic Compounds, 4 or More Rings
2
2026
23
0.460
 Why?
Female
53
2026
78763
0.460
 Why?
Purines
1
2016
187
0.460
 Why?
Chromatography, High Pressure Liquid
2
2015
581
0.450
 Why?
Drug Discovery
1
2016
154
0.440
 Why?
Serum
1
2015
57
0.440
 Why?
Adenosine
1
2016
256
0.430
 Why?
Intracellular Space
1
2014
64
0.420
 Why?
Kidney
4
2016
1498
0.420
 Why?
Priapism
1
2013
10
0.400
 Why?
Receptors, Adrenergic, alpha
1
2013
19
0.400
 Why?
HIV
4
2019
252
0.400
 Why?
Adrenergic alpha-Antagonists
1
2013
34
0.400
 Why?
Cytochrome P-450 CYP3A Inhibitors
1
2013
18
0.400
 Why?
Deoxycytidine
6
2017
222
0.390
 Why?
Treatment Outcome
15
2026
11831
0.390
 Why?
Telemedicine
1
2022
960
0.390
 Why?
Pre-Exposure Prophylaxis
5
2020
268
0.380
 Why?
Quinoxalines
2
2026
64
0.370
 Why?
Hepatitis B, Chronic
3
2022
22
0.370
 Why?
Hepatitis B virus
4
2024
33
0.370
 Why?
Genotype
7
2026
1853
0.360
 Why?
Gastric Bypass
1
2014
126
0.360
 Why?
Pyrrolidines
2
2026
125
0.360
 Why?
Area Under Curve
5
2026
329
0.350
 Why?
Phenotype
2
2016
3157
0.340
 Why?
Alanine
5
2025
170
0.330
 Why?
HIV Seronegativity
1
2010
29
0.330
 Why?
Antacids
1
2010
16
0.330
 Why?
Pyrrolidinones
1
2010
29
0.320
 Why?
Prospective Studies
17
2022
8039
0.320
 Why?
Pyrimidines
3
2021
520
0.310
 Why?
Patient Compliance
3
2017
587
0.310
 Why?
Pharmacy Service, Hospital
1
2011
89
0.300
 Why?
Blood Chemical Analysis
4
2019
110
0.300
 Why?
Plasma
4
2016
225
0.300
 Why?
Pregnancy Complications, Infectious
3
2025
437
0.290
 Why?
Reproducibility of Results
8
2016
3424
0.290
 Why?
Uridine Monophosphate
2
2019
16
0.290
 Why?
Sustained Virologic Response
4
2026
46
0.290
 Why?
Drug Prescriptions
1
2011
287
0.280
 Why?
Adolescent
21
2026
22485
0.270
 Why?
Fluorobenzenes
1
2008
17
0.270
 Why?
Drug Stability
5
2016
169
0.270
 Why?
Young Adult
17
2025
14192
0.260
 Why?
Guidelines as Topic
1
2009
270
0.260
 Why?
Liver Transplantation
1
2014
831
0.250
 Why?
Atazanavir Sulfate
5
2015
42
0.250
 Why?
Sensitivity and Specificity
5
2014
2002
0.240
 Why?
Half-Life
3
2015
153
0.240
 Why?
Anti-Ulcer Agents
1
2006
12
0.240
 Why?
Esomeprazole
1
2006
7
0.240
 Why?
Glycerophospholipids
2
2023
39
0.240
 Why?
Pharmacology, Clinical
1
2006
9
0.240
 Why?
Cyclopropanes
3
2026
84
0.230
 Why?
Hepatocytes
3
2016
224
0.230
 Why?
Education
1
2006
105
0.230
 Why?
Proton Pump Inhibitors
1
2006
109
0.220
 Why?
Aminoisobutyric Acids
2
2026
9
0.210
 Why?
Phosphates
3
2015
177
0.210
 Why?
South Africa
4
2015
266
0.210
 Why?
Milk, Human
1
2026
174
0.210
 Why?
Lactams, Macrocyclic
2
2026
51
0.210
 Why?
Leucine
2
2026
116
0.200
 Why?
Anemia
2
2016
190
0.200
 Why?
Biomarkers
5
2023
4283
0.200
 Why?
Variola virus
1
2022
3
0.190
 Why?
Smallpox
1
2022
10
0.190
 Why?
Health Personnel
1
2009
750
0.190
 Why?
World Health Organization
1
2022
104
0.180
 Why?
Delivery of Health Care
1
2009
948
0.180
 Why?
Linear Models
2
2014
848
0.170
 Why?
Drug Combinations
4
2026
397
0.170
 Why?
Blood Platelets
1
2025
380
0.170
 Why?
Lopinavir
3
2020
30
0.170
 Why?
Cross-Over Studies
4
2020
607
0.170
 Why?
Dideoxynucleosides
2
2023
24
0.170
 Why?
Point-of-Care Systems
1
2023
188
0.160
 Why?
Phosphorylation
2
2015
1707
0.160
 Why?
Interferons
2
2019
186
0.160
 Why?
Drug Administration Schedule
3
2019
782
0.150
 Why?
Neutrophils
1
2025
1124
0.150
 Why?
Arylamine N-Acetyltransferase
2
2026
8
0.150
 Why?
Homosexuality, Male
2
2017
232
0.140
 Why?
Nucleic Acids
1
2019
72
0.140
 Why?
Quality Control
2
2015
164
0.140
 Why?
Organic Anion Transport Protein 1
2
2008
6
0.130
 Why?
Oxazines
1
2018
37
0.130
 Why?
Directly Observed Therapy
1
2017
15
0.130
 Why?
Bronchoalveolar Lavage Fluid
1
2020
636
0.130
 Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
2017
19
0.130
 Why?
Liver Cirrhosis
1
2019
287
0.130
 Why?
Pharmacogenetics
2
2016
173
0.130
 Why?
Inosine Triphosphate
1
2016
2
0.130
 Why?
Nitriles
2
2021
205
0.120
 Why?
Darunavir
2
2014
20
0.120
 Why?
Anemia, Hemolytic
1
2016
21
0.120
 Why?
Deoxyadenine Nucleotides
1
2016
15
0.120
 Why?
Deoxycytosine Nucleotides
1
2016
13
0.120
 Why?
Guanosine Triphosphate
1
2016
89
0.120
 Why?
Glass
1
2016
47
0.120
 Why?
Pharmacy
1
2017
32
0.120
 Why?
Molecular Targeted Therapy
1
2019
439
0.120
 Why?
Genitalia
1
2016
34
0.120
 Why?
Pregnancy Outcome
1
2020
497
0.120
 Why?
Drug Packaging
1
2016
41
0.120
 Why?
Disease Transmission, Infectious
1
2017
69
0.120
 Why?
Syringes
1
2016
49
0.120
 Why?
Drug and Narcotic Control
1
2016
24
0.120
 Why?
Furans
2
2026
27
0.120
 Why?
Infant
6
2026
10064
0.120
 Why?
Zika Virus
1
2017
136
0.120
 Why?
Viremia
3
2022
160
0.120
 Why?
Pyridones
1
2018
208
0.120
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2011
442
0.120
 Why?
Benzopyrans
2
2026
30
0.120
 Why?
Fibroblast Growth Factors
2
2014
188
0.120
 Why?
Polymers
1
2019
494
0.110
 Why?
Polymorphism, Single Nucleotide
2
2016
2146
0.110
 Why?
Biological Assay
1
2016
129
0.110
 Why?
Cytosol
1
2016
214
0.110
 Why?
Creatinine
2
2018
513
0.110
 Why?
Practice Guidelines as Topic
2
2016
1585
0.110
 Why?
Piperazines
1
2018
378
0.110
 Why?
Rectum
1
2016
183
0.110
 Why?
Population
1
2015
30
0.110
 Why?
Brain Diseases
1
2016
153
0.110
 Why?
Nonlinear Dynamics
1
2015
96
0.110
 Why?
Analgesics
1
2017
233
0.110
 Why?
Chemical and Drug Induced Liver Injury
1
2016
138
0.110
 Why?
Liver Function Tests
1
2015
105
0.110
 Why?
Retrospective Studies
4
2020
17269
0.110
 Why?
Pharmaceutical Preparations
1
2016
170
0.110
 Why?
CD4 Lymphocyte Count
2
2015
280
0.110
 Why?
Virus Replication
1
2017
527
0.100
 Why?
Least-Squares Analysis
1
2014
74
0.100
 Why?
Mental Health Services
1
2019
472
0.100
 Why?
Child, Preschool
5
2026
11837
0.100
 Why?
Adenosine Triphosphate
1
2016
503
0.100
 Why?
Infectious Disease Transmission, Vertical
3
2025
194
0.100
 Why?
Pharmacists
1
2017
259
0.100
 Why?
Administration, Oral
3
2019
863
0.100
 Why?
Metabolic Clearance Rate
2
2018
115
0.100
 Why?
Hypophosphatemia
1
2013
17
0.100
 Why?
Cholecalciferol
1
2014
61
0.100
 Why?
Diphosphates
3
2021
20
0.100
 Why?
Calcitriol
1
2013
57
0.100
 Why?
Double-Blind Method
3
2013
2060
0.100
 Why?
Liver Diseases
1
2016
304
0.100
 Why?
Tablets
2
2023
41
0.100
 Why?
Cytochrome P-450 CYP3A
1
2013
93
0.090
 Why?
Leukocytes
1
2014
295
0.090
 Why?
Monocytes
1
2015
536
0.090
 Why?
Desiccation
1
2012
26
0.090
 Why?
Case-Control Studies
3
2024
3619
0.090
 Why?
Benzoxazines
1
2012
31
0.090
 Why?
Kidney Diseases
1
2016
427
0.090
 Why?
Organic Anion Transporters
1
2011
13
0.090
 Why?
Diabetes Mellitus
1
2020
1076
0.090
 Why?
Levonorgestrel
1
2012
34
0.090
 Why?
Pravastatin
1
2011
45
0.090
 Why?
Interferon-alpha
1
2012
194
0.090
 Why?
Benchmarking
2
2024
190
0.090
 Why?
Nucleosides
1
2011
25
0.090
 Why?
Vitamin D Deficiency
1
2013
190
0.080
 Why?
Contraceptive Agents, Female
1
2012
80
0.080
 Why?
Specimen Handling
1
2012
189
0.080
 Why?
Raltegravir Potassium
1
2010
18
0.080
 Why?
Body Weight
1
2015
970
0.080
 Why?
Hospitals, University
1
2011
176
0.080
 Why?
Models, Statistical
1
2015
679
0.080
 Why?
Mental Disorders
1
2019
1157
0.080
 Why?
Sex Distribution
1
2011
387
0.080
 Why?
Patient Acceptance of Health Care
1
2017
884
0.080
 Why?
Dietary Supplements
1
2014
580
0.080
 Why?
Cohort Studies
2
2019
5992
0.070
 Why?
Sex Characteristics
1
2015
779
0.070
 Why?
Mycobacterium tuberculosis
1
2012
339
0.070
 Why?
Aged
5
2018
26125
0.070
 Why?
Lamivudine
2
2023
65
0.070
 Why?
Time Factors
4
2016
7171
0.070
 Why?
Rosuvastatin Calcium
1
2008
21
0.070
 Why?
Logistic Models
2
2026
2130
0.070
 Why?
Child
5
2026
22680
0.070
 Why?
Immunosuppressive Agents
1
2012
842
0.060
 Why?
Pregnancy
4
2025
7197
0.060
 Why?
Kidney Calculi
1
2007
44
0.060
 Why?
Gene Frequency
1
2008
483
0.060
 Why?
Portugal
1
2006
10
0.060
 Why?
Quebec
1
2006
10
0.060
 Why?
Education, Medical
1
2009
273
0.060
 Why?
Self Report
2
2021
871
0.060
 Why?
Observational Studies as Topic
1
2026
133
0.060
 Why?
Internationality
1
2006
156
0.060
 Why?
Hematocrit
2
2016
108
0.050
 Why?
Dementia
1
2009
325
0.050
 Why?
Referral and Consultation
1
2011
862
0.050
 Why?
Sexual and Gender Minorities
2
2019
260
0.050
 Why?
United States
4
2017
16115
0.050
 Why?
Predictive Value of Tests
2
2019
2129
0.050
 Why?
Postpartum Period
1
2026
373
0.050
 Why?
Isoindoles
1
2022
5
0.050
 Why?
Lipids
1
2008
709
0.050
 Why?
Monkeypox virus
1
2022
23
0.050
 Why?
Risk Assessment
1
2012
3759
0.050
 Why?
Calibration
2
2013
154
0.040
 Why?
Demography
1
2022
287
0.040
 Why?
RNA, Viral
1
2026
693
0.040
 Why?
Treatment Failure
1
2023
365
0.040
 Why?
Benzamides
1
2022
224
0.040
 Why?
Computer Simulation
2
2016
1026
0.040
 Why?
Infant, Newborn
2
2026
6437
0.040
 Why?
Temperature
2
2016
681
0.040
 Why?
Animals
4
2022
38141
0.040
 Why?
Drug Approval
1
2020
93
0.040
 Why?
Tissue Donors
1
2023
421
0.040
 Why?
Dose-Response Relationship, Drug
2
2016
2030
0.040
 Why?
Lactation
1
2020
193
0.040
 Why?
Models, Biological
2
2016
1815
0.030
 Why?
Developing Countries
1
2020
317
0.030
 Why?
Chemistry Techniques, Analytical
1
2018
20
0.030
 Why?
Hair
1
2018
86
0.030
 Why?
Flaviviridae
1
2017
10
0.030
 Why?
Inhibitory Concentration 50
1
2017
90
0.030
 Why?
Vero Cells
1
2017
84
0.030
 Why?
A549 Cells
1
2017
75
0.030
 Why?
Drug Repositioning
1
2017
40
0.030
 Why?
Body Mass Index
1
2026
2425
0.030
 Why?
Pharmaceutical Solutions
1
2016
14
0.030
 Why?
Chromatography, Reverse-Phase
1
2016
27
0.030
 Why?
Breast Feeding
1
2020
447
0.030
 Why?
Drug Storage
1
2016
53
0.030
 Why?
Defective Viruses
1
2016
5
0.030
 Why?
Cities
1
2017
144
0.030
 Why?
Patient Selection
1
2020
742
0.030
 Why?
Acute Disease
1
2019
1040
0.030
 Why?
Solubility
1
2016
237
0.030
 Why?
Drug Compounding
1
2016
107
0.030
 Why?
Methanol
1
2016
45
0.030
 Why?
Alcohol Drinking
1
2023
837
0.030
 Why?
Spermatozoa
1
2016
108
0.030
 Why?
Solutions
1
2016
166
0.030
 Why?
Clinical Trials as Topic
1
2020
1058
0.030
 Why?
Administration, Inhalation
1
2016
571
0.030
 Why?
Hydrogen-Ion Concentration
1
2016
563
0.030
 Why?
Cold Temperature
1
2016
209
0.030
 Why?
Blood-Brain Barrier
1
2016
157
0.030
 Why?
Risk-Taking
1
2017
325
0.030
 Why?
Comorbidity
1
2019
1659
0.030
 Why?
Interleukins
1
2016
249
0.030
 Why?
DNA, Viral
1
2016
357
0.030
 Why?
Pregnancy Complications
1
2020
612
0.030
 Why?
Vitamin D-Binding Protein
1
2013
16
0.030
 Why?
Recurrence
1
2017
1142
0.020
 Why?
Feasibility Studies
1
2017
1119
0.020
 Why?
Parathyroid Hormone
1
2013
114
0.020
 Why?
Mental Health
1
2019
795
0.020
 Why?
Algorithms
1
2020
1855
0.020
 Why?
Water
1
2016
468
0.020
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
261
0.020
 Why?
Therapeutic Equivalency
1
2012
31
0.020
 Why?
Cell Line
1
2017
2823
0.020
 Why?
Alkynes
1
2012
66
0.020
 Why?
Anion Exchange Resins
1
2011
8
0.020
 Why?
Zidovudine
1
2011
77
0.020
 Why?
Food-Drug Interactions
1
2010
11
0.020
 Why?
Reference Standards
1
2011
178
0.020
 Why?
Chemoprevention
1
2010
92
0.020
 Why?
Epithelial Cells
1
2016
1112
0.020
 Why?
Latent Tuberculosis
1
2011
71
0.020
 Why?
Longitudinal Studies
1
2018
2950
0.020
 Why?
Haplotypes
1
2011
498
0.020
 Why?
Cholesterol
1
2011
405
0.020
 Why?
Glomerular Filtration Rate
1
2013
765
0.020
 Why?
Triglycerides
1
2011
518
0.020
 Why?
AIDS Dementia Complex
1
2009
52
0.020
 Why?
Polymorphism, Genetic
1
2011
616
0.020
 Why?
Follow-Up Studies
1
2017
5426
0.020
 Why?
Acquired Immunodeficiency Syndrome
1
2009
237
0.020
 Why?
Cross-Sectional Studies
1
2019
5891
0.020
 Why?
Antiemetics
1
1987
51
0.020
 Why?
Positron-Emission Tomography
1
2009
343
0.020
 Why?
Calcium
1
2013
1190
0.020
 Why?
Vomiting
1
1987
132
0.020
 Why?
Gene Expression Regulation
1
2016
2594
0.020
 Why?
Aged, 80 and over
1
2018
8326
0.010
 Why?
Neuropsychological Tests
1
2009
1139
0.010
 Why?
Brain
1
2016
2944
0.010
 Why?
Age Factors
1
2011
3340
0.010
 Why?
Alzheimer Disease
1
2009
631
0.010
 Why?
Magnetic Resonance Imaging
1
2009
3897
0.010
 Why?
Antineoplastic Agents
1
1987
2207
0.010
 Why?
Flunitrazepam
1
1987
3
0.000
 Why?
Metoclopramide
1
1987
19
0.000
 Why?
Methylprednisolone
1
1987
58
0.000
 Why?
Kiser's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (362) concept(s)
_
Co-Authors Expand Description
See all (31) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)